BOOTHBAY FUND MANAGEMENT, LLC
Position in RLMD — Relmada Therapeutics, Inc.
CIK 1549230
NEW YORK, NY
Position in RLMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,074,222
+$1,039,723 QoQ
Shares Held
729,055
-12.7% QoQ
Ownership
0.695%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Derivatives in RLMD
reported options exposure · as of Sep 30, 2022CallValue
$5,053,230
CallShares
136,500
PutValue
$5,053,230
PutShares
136,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $541,743,620 across 143 Biotechnology names. RLMD ranks #28 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
472,961 | $52,664,207 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
438,595 | $42,653,363 | |
| 3 | EXEL |
Exelixis, Inc.
|
803,866 | $34,477,812 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
522,019 | $30,334,524 | |
| 5 | MLYS |
Mineralys Therapeutics, Inc.
|
1,001,728 | $27,136,811 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
486,170 | $25,630,882 | |
| 7 | CGEM |
Cullinan Therapeutics, Inc.
|
1,112,803 | $15,812,930 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
270,412 | $15,724,457 |
All Filings in RLMD
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,074,222 | 729,055 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,034,499 | 835,300 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,393,404 | 693,236 | Shares | Other | 2025-11-14 | |
| 2023-06-30 | $31,468 | 12,792 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $28,909 | 12,792 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $44,644 | 12,792 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $5,053,230 | 136,500 | Call | Other | 2022-11-14 | |
| 2022-09-30 | $5,053,230 | 136,500 | Put | Other | 2022-11-14 | |
| 2022-06-30 | $727,317 | 38,300 | Call | Other | 2022-08-15 | |
| 2022-06-30 | $691,236 | 36,400 | Put | Other | 2022-08-15 | |
| 2021-06-30 | $752,235 | 23,500 | Call | Other | 2021-08-17 | |
| 2021-06-30 | $1,099,639 | 34,353 | Shares | Other | 2021-08-17 | |
| 2021-03-31 | $1,169,359 | 33,211 | Shares | Other | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||